Delivery Order SPE2DB22D3009-SPE2DB24FAQ86
Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $3.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $27,368.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a Delivery Order contract for the supply of 4563618123 - Ondansetron HCL 4 mg Tablets in 30-count packages. The contract has a firm fixed price and an ultimate completion date of February 12, 2024. The award was made without a set-aside designation, indicating full and open competition....
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of Ondansetron HCL 8 mg tablets. The fixed-price contract has a ceiling value of $1,472.38 and an ultimate completion date of January 8, 2024. This delivery order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award, valued at $7,307.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,563,501,307 tablets of Ondansetron Hydrochloride 8 mg. The contract has an ultimate completion date of February 1, 2024 and is structured as a Firm Fixed Price Delivery Order. The award was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,689.44, is for the delivery of Ondansetron HCL 8 mg tablets. The award is a Delivery Order contract, with a Firm Fixed Price pricing type, and an ultimate completion date of February 1, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,944.53, is for the delivery of Ondansetron HCL 8 mg tablets to support military and government healthcare programs. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,873.18, is for the delivery of Ondansetron HCL 8 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is April 18, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award, valued at $4,235.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,559,735,862 units of the pharmaceutical product Ondansetron HCL 4 mg Tablet in 30-count packages. The contract has a completion date of January 27, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,803.50, is for the delivery of ondansetron odt 8 mg tablets and is designated as a firm fixed price delivery order. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award, valued at $9,782.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,416,379 units of Ondansetron HCL 4 mg Tablets in 30-count packages. This is a delivery order contract with a firm fixed-price pricing type, with a completion date of April 29, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $5,651.72, is for the delivery of 4 milligram ondansetron hydrochloride tablets. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 13, 2024. The contract was awarded on February 12, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...